Theralase Technologies Inc (TLT) 시세

They have had large placements that have been horrible to investors. Roger seems to have zero traction with obtaining funding and that could be the result of terrible relationships with tutes and past investors. I have no idea why he has come back to the helm. Not a wise choice but nothing you can do about it. They have no IR at present as the current one is a BOD member and personal friend of Roger. Obviously works cheap. Roger's wife is second in command at the company so it is all kept in house.Some of usshareholders are concerned they are going to run out of capital because they can only raise in paltry amounts and that is going to dry up.

Great product but is hindered by management that cannot raise money. At present they are still trying to tap a large investor(public news) to take down a chunk but still no bite. I have no idea what will move the stock anymore. Every bit of news put out is meant by manipulative selling on the Venture Exchange. I really like the inventor of the drug. She is a wonderful lady.

TLTFF needs coverage, News, something to entice investors, way to quiet

Caveat Emptor, nice news but the management is outta its league.

Great PR today from Canada. Wish the stock had more volume but the potential for a big move is there. We just have to get rid of the management team and bring in someone capable of raising funds. The stock price is very cheap.

Had warrants that expired Aug 2024 sold them . Bought shares of BIG.v . Big has found a very large ore deposit in Idaho . Profound science at TLT . Big pharma is corrupt .

Big should show $10 in 24 and multiples in 05 as they show how valuable it is .

“Cure for Cancer?”
Sounds good to Me.

Chart reader says a technical buy to .39 . We are so close to a boil over . Good luck !

https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?threadid=35384358

Chart reader says a technical buy to .39 . We are so close to a boil over . Good luck !

Some wording in patent gets us a temporary rejection . How the rest of it will roll out is beyond me at this time .

This is well said . https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?threadid=35321535

This is a treatment that kills cancer at the cellular level . If the first or 7th treatment doesn't get what is left , treat them again . No side effects ????

That 89% is for efficacy .

If we take out the wrong dose patients this poster says 89% .

https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?threadid=35291142

Post by Guzzi , TLT.v looks like the big time .

https://fortworthreport.org/2022/03/14/listen-this-ut-arlington-researcher-is-treating-cancer-with-light/

Thanks.. maybe the stock will pop..

after the next announcing of clinical results.. FEB 16-18 San Fran..

https://finance.yahoo.com/news/theralase-phase-ii-nmibc-clinical-120000686.html

Nice !

So far so good.. Theralase

In my thoughts as a small time stock watcher without any real insights into a company ..all I can really do is watch for sentiment in a stock chart then make some guesses.

Here is my latest guess on Theralase

Downward trend line broken = anticipation?

I don't know but I do see sustained volume along with the trend.. and the Warrant extension (again) has me thinking that Theralase wants long term warrant holders to get paid. Seems logical and fair since timelines are difficult to predict when it comes to live human testing.

I am taking all of this as a positive in advance of.. wait for it....news. Just like every other stock I dabble in.

Good summary of what TLTFF has . https://stockhouse.com/companies/bullboard?symbol=v.tlt&postid=35183957

Insiders have loaded up . Time for news to show why and price to be proof .

https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=35015853

Great post from Stockhouse .

2 Separate Equity Offering in 2 weeks?

Oct 3 2022: https://finance.yahoo.com/news/theralase-commences-2-5-m-110000381.html

Sep 29 2022 https://finance.yahoo.com/news/theralase-announces-warrant-extension-210100300.html

Sep 22 2022: https://finance.yahoo.com/news/theralase-closes-2-5m-private-215500303.html

All of this action looks to set 2023 as the year for Theralase

Good timing for Theralase re:Biden

I like the moonshot analogy.. are we closer to the moon than we appear?

Someone thinks Theralace arrived.

Truth be told I don't have any facts except noting that the volume moving up over the last month has buoyed my spirit.

If cheap share were to be had they are going fast...er

This poster thinks we are almost at the point of proof .

https://stockhouse.com/companies/bullboard?symbol=v.tlt&postid=34954321

This stockhouse poster has a + view and the #s on TLT.

https://stockhouse.com/companies/bullboard?symbol=v.tlt&postid=34940829

Looks a bit like TLT ?????????? https://stockhouse.com/companies/bullboard?symbol=v.tlt&postid=34939963

The downside risk is very low . The upside could be high

Quarterly Update..

Seemes like positive growth despite
losing money.. that's expected.. isn't it?

Anyone read " Jessie Stine's " book ?

Egon. post at 4126 answers those ? of a long term investment .

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168672114

The board needs the opinion of a knowing trader . How can you place a value on this if it kills all cancers . How will it play out if it does .

Most likely play if it doesn't . How can you get a fair price for it ?

94.4 % kill of cancer out of 38 treated . Have to keep the mess ups in the data to keep the confusion . This poster figures it out .


https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34794725

Looking good

Thanks BigK

Informed poster https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34750757

Total Evaluable Patients - Great Updates

Total Patient population and Total Optimized Patient population

https://postimg.cc/mPLRXpp4

Updated from April 5 to April 29:

https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34650518

All references in this post from Stockhouse and their respective authors/members.

Good luck to all. Regards,BK

To have a Complete Response 53 % . 24 % we will know in a few days . Potential 77 % . Beyond to 90's is still open .

Nearest competitor 28 % .At some point going to get rough on the other guys .

We are close to a breakaway . If your science is sound buy them when they go on sale .

Eogan. tells us what TLT has achieved and what they further expect to do .

https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34633988

Warrants will not be paid move ? Warrants due end of month ?

Might be the simplest/clearest understanding of the treatment mess . https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34627578

This is an interpretation of data that is helpful . https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34612170

Is this the explanation ? https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34606918

Here is a criticism that to me is valid . Perhaps not buying until over $ 1 is the wise choice . https://stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc?postid=34606739

$TLTFF - receives a target raise from Research Capital

Published on April 5, 2022

New interim clinical data has Research Capital Corporation analyst Andr Uddin feeling more bullish about Canadian drug developer Theralase Technologies (Theralase Technologies Stock Quote, Charts, News, Analysts, Financials TSXV:TLT). Uddin maintained a “Speculative Buy” rating while raising his target price from $0.70/share to $1.20/share for a projected return of 161 per cent in an update to clients on Tuesday.

Theralase Technologies receives a target raise from Research Capital (cantechletter.com/)

Thnks !

Theralase Technologies receives a target raise from Research-Capital

123414 Still long TLTFF.

The 67% CR@ 18/24 months is unmatched.

Those full dose patients are becoming dominate in the study.

Under-treaded patients are still in the mix but getting reduced.
AND... Now the kicker... the undertreated patients were not treated in the protocol of the study.

Read what the analysis says about all the one dose patients.

TLTFF on track and still solid as heck.

That's why that analyists moved his rating to .95usd / 1.20cad

He nailed it before.

Stay tuned sports fan the race is just heating up.

Theralase Technologies receives a target raise from Research-Capital

https://www.cantechletter.com/2022/04/theralase-technologies-receives-a-target-raise-from-research-capital/

123414 Take it you bailed ? The science is to fall in love with , the execution is to bring tears .

Buy today results are great . https://www.siliconinvestor.com/readmsg.aspx?msgid=33789452

The full Doses are now becoming dominant in the study.
The first ph2 12 patients who were under treated in the first dose negativly affected the CR rates.

Now the full dose patients are starting to show up at the data points.

It's gonna be good.

SEC violation
1 april 2022

TLTFF TRADE 10 -11:32am 43s
TLTFF TRADE 11 11:33am 58s

RE 10 @ 3704
RE 10 @ 3726

Exucuted Trades not recorded on 1 min chart

SEC violation???

I